The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.

Soler MJ, Daza-Arnedo R, Ramos N, Rico-Fontalvo J

Open source

DOI
10.1016/j.kint.2023.10.027
Published
2024 Feb
Container
Kidney international
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.kint.2023.10.027,
  title = {The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.},
  author = {Soler MJ and Daza-Arnedo R and Ramos N and Rico-Fontalvo J},
  year = {2024},
  journal = {Kidney international},
  doi = {10.1016/j.kint.2023.10.027},
  url = {https://doi.org/10.1016/j.kint.2023.10.027}
}

RIS

TY  - JOUR
TI  - The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.
AU  - Soler MJ
AU  - Daza-Arnedo R
AU  - Ramos N
AU  - Rico-Fontalvo J
PY  - 2024
JO  - Kidney international
DO  - 10.1016/j.kint.2023.10.027
UR  - https://doi.org/10.1016/j.kint.2023.10.027
ER  - 

APA

MJ, S., R, D., N, R., & J, R. (2024). The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.. Kidney international. https://doi.org/10.1016/j.kint.2023.10.027

Source records